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Spinocerebellar ataxia type 3 
Machado–Joseph disease 
Deubiquitinating enzyme 
a b s t r a c t 
Protein ubiquitination occurs through formation of an isopeptide bond between the C-terminal glycine
of ubiquitin (Ub) and the ε -amino group of a substrate lysine residue. This post-translational modiﬁca-
tion, which occurs through the attachment of single and / or multiple copies of mono-ubiquitin and poly-
ubiquitin chains, is involved in crucial cellular events such as protein degradation, cell-cycle regulation
and DNA repair. The abnormal functioning of ubiquitin pathways is also implicated in the pathogenesis
of several human diseases ranging from cancer to neurodegeneration. However, despite the undoubted
biological importance, understanding the molecular basis of how ubiquitination regulates different
pathways has up to now been strongly limited by the difﬁculty of producing the amounts of highly
homogeneous samples that are needed for a structural characterization by X-ray crystallography and /
or NMR. Here, we report on the production of milligrams of highly pure Josephin mono-ubiquitinated
on lysine 117 through large scale in vitro enzymatic ubiquitination. Josephin is the catalytic domain of
ataxin-3, a protein responsible for spinocerebellar ataxia type 3. Ataxin-3 is the ﬁrst deubiquitinating
enzyme (DUB) reported to be activated by mono-ubiquitination. We demonstrate that the samples pro-
duced with the described method are correctly folded and suitable for structural studies. The protocol
allows facile selective labelling of the components. Our results provide an important proof-of-concept
that may pave the way to new approaches to the in vitro study of ubiquitinated proteins. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical











 1. Introduction 
Post-translational modiﬁcations of proteins regulate a wide vari-
ety of cellular events [ 1 ]. One the most important of such modiﬁca-
tions is ubiquitination, a reaction ﬁrst described ∼40 years ago [ 2 ]. It
consists of the covalent attachment of the ε -amino group of a target
protein lysine to the carboxylic group of ubiquitin C-terminal glycineAbbreviations: ATP, adenosine triphosphate; DTT, dithiothreitol; DUB, deubiquiti- 
nating enzyme; GST, glutathione-S-transferase; HSQC, heteronuclear single quantum 
coherence; IAA, iodoacetamide; JosK117-only, Josephin mutant in which all lysines but 
K117 are mutated; MS / MS tandem, mass spectrometry; NMR, nuclear magnetic reso- 
nance; PDB, Protein Data Bank; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis; Tris–HCl, 2-amino-2-(hydroxymethyl)-1,3-propanediol hydrochlo- 
ride. 
* Corresponding author. Tel.: + 44 2088162630. 
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http://dx.doi.org/10.1016/j.fob.2013.10.005 via an isopeptide bond. In vivo , ubiquitin conjugation is performed
by a cascade of three classes of enzymes, named ubiquitin-activating
enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin lig-
ases (E3), and is reversed by deubiquitinating enzymes (DUBs). Pro-
teins can be mono-ubiquitinated, multi-monoubiquitinated, or poly-
ubiquitinated [ 3 , 4 ]. Initially, ubiquitin was described as a molecular
death-tag, promoting protein degradation by the proteasome [ 5 , 6 ].
More recently, several other roles of ubiquitin have been discovered,
broadening the ﬁeld of action of the protein to cellular processes
such as signalling, cell cycle regulation, and DNA repair [ 7 –9 ]. Mono-
ubiquitination can also have different functional consequences for
a target protein, such as changes in binding properties, subcellular
localization and activity [ 10 ]. 
Despite its fundamental biological role, very little is known about
how ubiquitination inﬂuences the structure / functions of the cova-
lently linked cargo proteins. Yet, unlike other less invasive modiﬁ-
cations such as phosphorylation, which introduces a relatively small
group (80 Da), ubiquitination results in the addition of one or more
repeats of a globular protein of 76 amino acids (about 8.5 kDa). Thean Biochemical Societies. Open access under CC BY-NC-ND license.



























































Fig. 1. Scheme of the protocol set up for the production of mono-ubiquitinated 
JosK117-only. 
 nteraction between ubiquitin and the cargo protein could thus pro- 
uce major conformational changes. The main reason for this lack 
f knowledge is that the production of ubiquitinated proteins in the 
mounts required for structural characterization remains challenging 
 11 ]. 
The relatively few structures available in Protein Data Bank (PDB) 
f proteins bound to ubiquitin correspond either to non-covalent 
omplexes, or to complexes in which the C-terminal glycine of ubiq- 
itin is covalently bound through a thioester bond to a cysteine of 
 substrate protein. Among this second group are enzymes with a 
eactive cysteine in the active site having ubiquitin (i.e. E1, E2, and 
3 enzymes) or ubiquitin chains (i.e. DUBs) as a substrate. For DUBs 
n particular, ubiquitin covalent binding is obtained using suicidal ir- 
eversible inhibitors as ubiquitin aldheyde or ubiquitin vinyl sulfone 
 12 –18 ]. The structures of these enzymes correspond to bona ﬁde re- 
ction intermediates, in which the substrate (ubiquitin) is covalently 
inked to the active site. While appropriate for speciﬁc examples, 
his approach remains highly unsatisfactory to describe the effect of 
biquitination as it signiﬁcantly alters the structural and geometrical 
elationship between cargo and ubiquitin. 
Different chemical and enzymatic strategies have more recently 
een proposed to covalently link the ε -amino group of a target protein 
ysine to the carboxylate group of the C-terminal glycine of ubiqui- 
in. Non-enzymatic strategies consist in semi-synthetic methods that 
ften exploit intein chemistry and multiple protection and deprotec- 
ion steps [ 19 ]. Histone H2B and α-synuclein have, for instance, been 
ono-ubiquitinated using chemical ligation [ 19 , 20 ]. Several chemi- 
al methods consist in the formation of isopeptide bond mimics [ 21 ]. 
 new synthetic method named GOLAP could potentially be applied 
o protein ubiquitination, but it requires protein refolding after liga- 
ion [ 22 , 23 ]. A different approach is based on the use of E1, E2 and
3 enzymes to catalyze the formation of a native isopeptide bond. A 
ecent paper suggests the co-expression in Escherichia coli of all the 
roteins necessary for the ubiquitination cascade [ 24 ]. These methods 
re, however, overall laborious and of not easy implementation. 
Here, we show how we can, through the careful setup and opti- 
ization of an enzymatic in vitro approach, produce milligrams of a 
ono-ubiquitinated protein in quantities suitable for structural stud- 
es. We used Josephin that is the catalytic domain of ataxin-3, a DUB 
esponsible for spinocerebellar ataxia of type 3 (or Machado–Joseph 
isease). Josephin is a papain-like cysteine protease that preferen- 
ially cleaves long ubiquitin chains [ 25 ]. The crystal structure of the 
osephin domain of an ataxin-3-like protein covalently attached to 
biquitin through the catalytic cysteine has been published [ 26 ]. This 
omplex is representative of how Josephin interacts with its sub- 
trate. However, besides binding ubiquitin as a substrate, ataxin-3 can 
tself be mono-ubiquitinated in the cell with the major site of ubiq- 
itination being lysine 117 on the Josephin domain [ 27 , 28 ]. Mono- 
biquitination results in the increase of the DUB activity of the protein 
hrough a still elusive molecular mechanism [ 27 , 28 ]. Understanding 
ow ubiquitination leads to enzyme activation demands the produc- 
ion of properly (through an isopeptide bond) mono-ubiquitinated 
osephin. Our goal was therefore to produce a homogeneous sam- 
le of Josephin mono-ubiquitinated at lysine 117 in quantities (mg) 
menable for structural studies. The strategy that we describe consti- 
utes an important proof-of-concept and a new step towards under- 
tanding protein regulation by ubiquitination. 
. Results 
.1. Mono-ubiquitinated Josephin can be produced in vitro 
nzymatically 
The pipeline followed in this paper is summarized in Fig. 1 . 
We have previously demonstrated that lysine 117 is the primary 
ite of ubiquitination of Josephin both in vitro and in cells [ 28 ]. However, it cannot in principle be ruled out that minor fractions 
of Josephin are ubiquitinated on a different lysine residue [ 28 ]. Since 
sample homogeneity is an essential prerequisite for structural stud- 
ies, we used a Josephin mutant (JosK117-only), in which all lysines 
but K117 (i.e. K8, 85, 125, 128 and 166) were mutated to arginines. 
These mutations will direct ubiquitination speciﬁcally on lysine 117. 
According to a previously described protocol [ 27 ], in vitro ubiquitina- 
tion of Josephin can be catalyzed by 0.16 μM E1, 8 μM UbcH5a and 
1 μM CHIP, 50 μM Ub, 4.5 mM MgCl 2 , 4.5 mM ATP in buffer 50 mM 
Tris–HCl, 50 mM KCl, 0.2 mM DTT, pH 7.5 for 2 h at 37 ◦C. However, 
our previous studies on Josephin stability demonstrated that the pro- 
tein is prone to aggregation [ 30 ], and that temperature and / or high 
ionic strength increase the tendency of Josephin to form aggregates. 
To reduce the risk of protein aggregation, the enzymatic reaction was 
run at 25 ◦C for 20 h instead of 37 ◦C for 2 h and no KCl was added to
the ubiquitination buffer. Commercial enzymes were initially used to 
set up the protocol for large-scale production of mono-ubiquitinated 
Josephin. Samples from the reaction mixture were collected before 
addition of ATP ( t = 0), after 3 and 20 h. A band at about 30 kDa, 
corresponding to the molecular weight of JosK117-only (c.a. 21 kDa) 
covalently linked to ubiquitin (c.a. 8.5 kDa) appeared after 3 h and 
its intensity increased over time as the mono-ubiquitinated product 
formed ( Fig. 2 , lane s 1–3). In parallel, JosK117-only and ubiquitin were 
consumed. We then increased the concentrations of E1, UbcH5a, and 
CHIP to ubiquitinate the majority of JosK117-only in the mixture. At 
the same time, we scaled up Josephin and ubiquitin concentrations 
from 12 μM and 50 μM to 50 μM and 250 μM, respectively ( Fig. 2 , 
lanes 4–6). Using these conditions, we obtained a satisfactory yield of 
mono-ubiquitinated Josephin. 
2.2. Scaling-up the sample production 
The formation of the mono-ubiquitinated product further in- 
creased using enzymes puriﬁed in the laboratory ( Fig. 2 , lanes 7–9). 
Since we could produce large amounts of enzymes, we were able 
to work with larger total volumes of the mixture, which ranged be- 
tween 5 and 15 ml. These amounts would be prohibitively expensive 
when using commercial enzymes. The yield of mono-ubiquitinated 
product remained comparable to that obtained in the small-scale tri- 
als. Mono-ubiquitinated JosK117-only is the most abundant product 
of ubiquitination with the highest yields obtained after overnight 
reaction ( Fig. 2 , lane 9). However, we observed also other side- 
products which form along with mono-ubiquitinated JosK117-only: 
unanchored poly-ubiquitin chains and poly-ubiquitinated Josephin 
species. Unanchored ubiquitin chains form by the catalytic action of 
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Fig. 2. In vitro ubiquitination of JosK117-only. All reactions are monitored at t = 0, 3 and 
20 h. Lanes 1–3: reaction using commercial enzymes (0.16 μM E1, 8 μM UbcH5a and 1 
μM CHIP), 50 μM ubiquitin and 12 μM JosK117-only at room temperature [ 27 ]. Lanes 
4–6: reaction using commercial enzymes (1 μM E1, 8 μM UbcH5a, 8 μM CHIP), 250 μM 
ubiquitin and 50 μM JosK117-only. Lanes 7–9: reaction using enzymes prepared in the 
lab at the ﬁnal concentrations as in lanes 4–6. Lanes 10–12: reaction using Josephin 
pre-treated with IAA. Lane 13: puriﬁed mono-ubiquitinated JosK117-only. Lane 14: 
molecular weight marker. Di-ubiquitin and poly-ubiquitin chains are indicated with 
arrows. The bands of E1, E2 and E3 enzymes are indicated with annotation below each 
corresponding band. The Addgene clone of UbcH5a used for the production in the lab 
comprise an initial sequence deriving from cloning which explains the higher MW with 































Fig. 3. Anion exchange puriﬁcation of mono-ubiquitinated JosK117-only. Absorbance 
at 280 nm (blue), 250 nm (red) and percentage of buffer B (1 M NaCl) are reported. 
Mono-ubiquitinated JosK117-only elutes at ∼47 ml. (For interpretation of the refer- 







































 E1 and UbcH5a since UbcH5a is a promiscuous enzyme which forms
K48, K63 and K11 linkages [ 31 ]. The formation of di-ubiquitin can be
followed on the gel, corresponding to a band with apparent molecular
weight of 14 kDa ( Fig. 2 , bottom arrow). Longer ubiquitin chains gave
a characteristic smear band visible in the SDS–PAGE gel ( Fig. 2 , top
arrow). 
Interestingly, the overall intensity of the smear band is lower after
20 h compared to 3 h, as Josephin exploits its deubiquitinating activ-
ity ( Fig. 2 , lanes 8 and 9). This could be explained by considering that
Josephin is itself a DUB that is able to break both K48 and K63 linkages
in poly-ubiquitin chains [ 32 ]. To test this hypothesis, we blocked the
catalytic cysteine on Josephin with iodoacetamide (IAA), removed the
unreacted IAA and ran a parallel ubiquitination reaction ( Fig. 2 , lanes
10–12). We observed that Josephin inactivation causes a shift of the
smear band towards higher molecular weights, consistent with these
species not being cleaved by the catalytic inactive Josephin. Ubiqui-
tin is consumed faster and the overall amount of mono-ubiquitinated
product is reduced. This result shows that the yield of in vitro ubiq-
uitinated Josephin is inﬂuenced by its DUB activity and suggests that
Josephin removes the ubiquitin chains (but not the ﬁrst ubiquitin moi-
ety) attached to lysine 117. It is also likely that Josephin increases the
amount of substrate available for the ubiquitination since it breaks
the ubiquitin chains and releases mono-ubiquitin in the mixture. 
Other “unwanted” products of the enzymatic reaction are formed
by elongation of the ubiquitin chain on Josephin by UbcH5a / CHIP. We
clearly observed the formation of products with molecular weight of
about 39 kDa (Josephin + 2 Ub, band overlapped with CHIP) and
47 kDa (Josephin + 3 Ub) although longer products also form in
smaller amounts. To further increase the yield of mono-ubiquitinated
Josephin, we attempted to block chain elongation using either methy-
lated ubiquitin (Enzo Lifescience) or an E2 mutant, which cannot ex-
tend ubiquitin chains [ 27 ]. In both cases we obtained very low yields
of the mono-ubiquitinated product (data not shown). 2.3. Puriﬁcation of mono-ubiquitinated Josephin 
As an alternative to the strategy outlined above, we developed
a protocol for the separation of mono-ubiquitinated JosK117-only
from the poly-ubiquitinated products. Mono-ubiquitinated JosK117-
only was separated from poly-ubiquitinated products, unreacted sub-
strates and ubiquitination enzymes by anion exchange chromatogra-
phy ( Fig. 3 ). Initially all components of the reaction mixture are bound
to the column (including unreacted ATP and AMP produced by catal-
ysis). The presence of these nucleotides produces a strong UV signal,
which saturates the absorbance detector and covers protein peaks at
280 nm. ATP and AMP were conveniently separated from the proteins
directly on the column using a wash step at 0.1 M NaCl. 
A salt gradient was then applied to purify mono-ubiquitinated
JosK117-only. E1, UbcH5a, CHIP, unreacted ubiquitin, and ubiqui-
tin chains were easily removed as they elute at different NaCl con-
centrations with respect to all Josephin species. Mono-ubiquitinated
JosK117-only could be efﬁciently separated from unreacted and poly-
ubiquitinated Josephin species although the theoretical isoelectric
points are quite close (JosK117-only has a pI of 4.7 while that of
mono-ubiquitinated JosK117-only is 4.9). We applied a shallow salt
gradient, typically 0.1–0.3 M NaCl in a total buffer volume of about
300 ml. This method yielded to a high purity product as conﬁrmed by
SDS–PAGE ( Fig. 2 , lane 13). Mass spectrometry analysis after trypsin
digestion was performed to check the isopeptide bond formation.
Trypsin cleaves ubiquitin covalently-linked to a protein at the junc-
tion between arginine 74 and glycine 75, thus producing a GG signa-
ture. A peptide with mass corresponding to residues 111–124 from
JosK117-only plus the two C-terminal glycines from ubiquitin was
isolated ( Fig. 4 , top, right arrow). The data also comprise a peptide
with mass corresponding to the ﬁrst 10 amino acids of JosK117-only
( Fig. 4 , top, left arrow), but no peak with the same mass plus the GG
ubiquitin signature was found (expected mass of 1304 Da), exclud-
ing ubiquitination at the N-terminus. Fragmentation by MS / MS of
the peptide 111–124 conﬁrmed that K117 is linked via an isopeptide
bond to glycine 76 of ubiquitin ( Fig. 4 , bottom). 
2.4. Josephin mono-ubiquitination does not affect the fold 
To characterize the obtained sample, we compared the 1 H–15 N
HSQC spectrum of JosK117-only and Josephin wild-type to check the
effect of the introduced mutations (ﬁve lysines mutated to arginines).
The chemical shift variations are modest demonstrating that JosK117-
only has a very similar fold as compared to the wild-type protein
( Fig. 5 A). This proves that the conservative mutations introduced to
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Fig. 4. MS analysis of JosK117-only. Top: MS spectrum of mono-ubiquitinated JosK117-only after trypsin digestion. The left arrow corresponds to Josephin GAMESIFHER N-terminal 
peptide, the right arrow indicates the mass of amino acids 111–124 including the ubiquitin C-terminal GG dipeptide covalently attached to lysine 117. Bottom: fragmentation with 























apeciﬁcally direct ubiquitin covalent binding on lysine 117 do not 
lter the structure of the protein and that the mutant JosK117-only is 
n appropriate model to study Josephin ubiquitination. 
The protocol outlined here allows the facile selective labelling 
f the speciﬁc moieties. We can for instance produce 15 N labelled 
osK117-only attached to unlabelled ubiquitin ( Fig. 5 B) or 15 N labelled 
biquitin attached to unlabelled JosK117-only ( Fig. 5 C). 
The 1 H–15 N HSQC spectrum of mono-ubiquitinated Josephin pre- 
ared using 15 N JosK117-only and unlabelled ubiquitin was then 
ompared to the spectrum of unmodiﬁed 15 N JosK117-only ( Fig. 5 B). 
eak dispersion is similar in the two samples, conﬁrming that mono- 
biquitinated JosK117-only is well folded and excluding substantial 
ggregation. Several chemical shift variations are observed with re- 
pect to the non-ubiquitinated protein but, overall, the chemical shift 
alues do not change after ubiquitination for a good percentage of the 
esidues. Likewise, the spectrum of labelled ubiquitin varies in the 
biquitinated sample for some speciﬁc residues but without major 
verall perturbations ( Fig. 5 C). These data conﬁrm that ubiquitin on 
ysine 117 directly interacts with Josephin, but the interaction does 
ot have dramatic effects on the overall structure of the protein. 
.5. Discussion 
Here, we have described a method for the enzymatic production of 
ighly pure mono-ubiquitinated Josephin with a naturally occurring 
sopeptide bond. We report a protocol for a large-scale (mg) in vitro 
nzymatic production (using appropriate E1, E2 and E3 enzymes) of 
 protein mono-ubiquitinated at a physiological site with a native isopeptide bond. Our data should be compared with recent publica- 
tions that also describe large-scale in vitro ubiquitination for the pro- 
duction of samples for structural studies. A recent paper reported the 
structure of a RING E3 ligase, RNF4, in association with UbcH5a linked 
to ubiquitin [ 33 ]. The authors attached ubiquitin to the catalytic site of 
UbcH5a by insertion of a mutation C85K, where the catalytic cysteine 
was mutated to lysine and an isopeptide bond was formed in the pres- 
ence of E1 and ATP. Although the approach is in principle similar to 
ours, the product did not represent a protein mono-ubiquitinated on a 
lysine that is commonly ubiquitinated in vivo , but can rather be clas- 
siﬁed as an E2 reaction intermediate. Another publication reported 
an NMR characterization of mono-ubiquitinated Ras [ 34 ]. The sample 
was obtained by mutating the lysine known to be ubiquitinated in vivo 
to cysteine (Ras K147C), and introducing a cysteine at the C-terminus 
of ubiquitin (G76C mutant). The disulﬁde bond formed by oxidation 
of the cysteines mimics the native isopeptide bond but it cannot faith- 
fully reproduce its chemical nature and geometry. Interestingly, no 
effect on the HSQC spectrum was observed after this covalent binding 
(S–S) of ubiquitin. A similar approach (disulﬁde-mediated conjuga- 
tion) was also used for mono-ubiquitinated PCNA [ 35 ], by exploit- 
ing intein synthesis and chemical ligation. Mono-ubiquitinated PCNA 
was produced in another study by splitting the sequence in two auto- 
assembling fragments at the level of the lysine found to be ubiqui- 
tinated in vivo, and expressing ubiquitin together with the ﬁrst half 
of the protein [ 36 ]. The authors used two glycine residues as a linker 
in order to mimic the isopeptide bond. While certainly interesting, 
these approaches might substantially alter the nature of the linkage 
by changing its length and geometrical / chemical properties. Recently, 
Serena Faggiano et al. / FEBS Open Bio 3 (2013) 453–458 457 
Fig. 5. Comparison of NMR spectra of different Josephin samples. (A) 15 N HSQC spec- 
trum of labelled Josephin wild-type (in cyan) superimposed to the spectrum of labelled 
JosK117-only (in blue). (B) 15 N HSQC spectrum of labelled JosK117-only covalently 
linked to unlabelled ubiquitin (in green) superimposed to the spectrum of labelled 
JosK117-only (in blue). (C) 15 N HSQC spectrum of labelled ubiquitin covalently linked 
to unlabelled JosK117-only (in green) superimposed to the spectrum of labelled ubiq- 
uitin (in blue).The samples contain 300 μM proteins in 20 mM Na phosphate pH 6.5, 2 
mM DTT. The spectra were recorded at 700 MHz and 25 ◦C. (For interpretation of the 




















































  PCNA mono-ubiquitination was performed via enzymatic reaction in
order to obtain a sample for crystallization [ 37 ]. This is so far the only
structure deposited in PDB of a protein in which ubiquitin is linked by
a native isopeptide bond to a speciﬁc lysine reported to be ubiquiti-
nated in vivo . This work proves that the enzymatic approach we report
is suitable for the structural characterization of mono-ubiquitinated
proteins. 
The difﬁculty of producing samples of ubiquitinated proteins for
structural characterization has been a serious limitation to under-
standing yet unexplored allosteric and regulatory roles of ubiquitin
[ 11 , 21 ]. To date, the development of a general protocol for protein
ubiquitination seems still far from being in the reach but it is possible
that, given the diversity of the targets and of the enzymes involved,
generalization is intrinsically not possible. Our work sets an impor-
tant proof-of-concept which demonstrates that it is feasible to obtain
milligrams of a mono-ubiquitinated protein with a native isopeptide
bond through large scale in vitro ubiquitination. The homogeneous
product is suitable for a structural characterization by X-ray crystal-
lography and / or NMR. In particular, as shown here, different 15 N and
13 C isotope labelling schemes can easily be introduced in the ﬁnal
product to perform NMR studies and address speciﬁc questions. 
A side observation that could have more general applications is
that the DUB activity of Josephin helps reduce the formation of long
poly-ubiquitinated chains. Thus, we suggest that Josephin and / or
other DUBs could potentially be exploited for in vitro ubiquitination
of other substrates. Addition of even small quantities of these DUBs
could help to increase the mono-ubiquitination yields and have useful
biotechnological applications. 
In conclusion, the methodology described here constitutes the ﬁrst
step towards a thorough characterization of the properties of mono-
ubiquitated Josephin. Assignment of the NMR spectrum of mono-
ubiquitinated Josephin may now provide further details on the mode
of interaction of Josephin with ubiquitin covalently linked to K117.
Crystallization trials of mono-ubiquitinated Josephin have also been
initiated. This work will open entirely new avenues to unveil the
mechanism underlying the activation of ataxin-3 DUB activity in-
duced by ubiquitination. 
3. Materials and methods 
3.1. Protein expression 
The N-terminal Josephin domain of ataxin-3 (residues 1–182) hav-
ing all lysines but K117 mutated to arginines (JosK117-only) was pro-
duced as reported previously [ 28 , 29 ]. His-tagged human E1 expressed
in insect cells was purchased from the Monoclonal Antibody / Protein
Expression facility of the Baylor College of Medicine, Houston, Texas.
His-tagged UbcH5a (E2) was expressed in BL21(DE3) E. coli using the
Addgene plasmid 15782. CHIP (E3) in vector pGEX6P1 was produced
as GST-tagged. Puriﬁcation of E1 and UbcH5a was performed on a Ni-
NTA resin (Qiagen). CHIP was puriﬁed using a Glutathione Sepharose
matrix (GE Healthcare) and cleaved from GST with Prescission Pro-
tease (GE Healthcare). Commercial puriﬁed enzymes were purchased
from Enzo Life Science (E1 and UbcH5a) and Merck Millipore (CHIP).
Recombinant wild-type human ubiquitin was expressed as untagged
protein and puriﬁed by anion exchange using a Q Sepharose resin
followed by gel ﬁltration on a Sephadex G-100 column (GE Health-
care). 15 N labelled Josephin for NMR experiments was obtained by
expression in minimal medium containing 15 NH 4 Cl as the sole nitro-
gen source. 
3.2. Optimization of the conditions for Josephin ubiquitination 
Small scale in vitro ubiquitination (total volume 100 μl) was per-
formed using commercial enzymes at the concentrations indicated in































 odi et al. [ 27 ]. Reactions were run at 25 ◦C for 20 h. Josephin, ubiq- 
itin, E1, UbcH5a and CHIP concentrations were scaled-up to achieve 
 larger production of mono-ubiquitinated Josephin. Final concentra- 
ions were 50 μM JosK117-only, 1 μM E1, 8 μM UbcH5a, 8 μM CHIP, 
50 μM Ub. Recombinant enzymes expressed and puriﬁed in the lab 
ere used at the same concentrations. 
.3. Large scale in vitro ubiquitination 
The reaction was carried out at 25 ◦C for 20 h using 50 μM JosK117- 
nly, 1 μM E1, 8 μM UbcH5a, 8 μM CHIP, 250 μM Ub, 4.5 mM ATP, 
.5 mM MgCl 2 , in buffer 50 mM Tris pH 7.5, 0.5 mM DTT. The total 
olume used typically ranged between 5 and 15 ml. JosK117-only 
rotected with IAA was obtained after treatment with 20 mM IAA for 
 h in the dark. The sample was dialysed in 20 mM Na phosphate 
uffer, pH 6.5 to eliminate unreacted IAA. 
.4. Puriﬁcation of mono-ubiquitinated Josephin 
Mono-ubiquitinated JosK117-only was puriﬁed from the ubiquiti- 
ation mixture by anion exchange using a 5 ml Hi-Trap Q HP column 
GE Healthcare). The mixture was directly loaded on the column us- 
ng buffer 50 mM Tris–HCl pH 8.0, 2 mM DTT. After a ﬁrst wash step 
t 0.1 M NaCl, the protein was eluted with a linear salt gradient of 
.1–0.3 M NaCl, with a ﬂux of 1.5 ml / min, for a total length of 180 min.
he puriﬁed product run in a SDS–PAGE gel was digested with trypsin 
nd analyzed by liquid chromatography–tandem mass spectrometry 
LC–MS / MS) using an Orbitrap mass analyzer [ 28 ]. 
.5. NMR spectroscopy 
Mono-ubiquitinated Josephin ( 15 N labelled Josephin linked to un- 
abelled ubiquitin) was prepared in 20 mM Na phosphate, pH 6.5, 
 mM DTT at a concentration of 300 μM. Measurements were per- 
ormed at 25 ◦C on a Bruker 700 MHz spectrometer. 
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